NCT02178072View on ClinicalTrials.gov

Window Trial 5-aza in HNSCC, T-tare

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 19, 2015

Primary Completion Date

October 23, 2019

Study Completion Date

October 23, 2019

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

5-Azacitadine

Trial Locations (1)

06510

Smilow Cancer Center at Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02178072 - Window Trial 5-aza in HNSCC, T-tare | Biotech Hunter | Biotech Hunter